Articles by Lara Yoon, MPH
Understanding and Improving Value Frameworks With Real-World Patient Outcomes
ByAnupam B. Jena, MD, PhD,Jacquelyn W. Chou, MPP, MPL,Lara Yoon, MPH,Wade M. Aubry, MD,Jan Berger, MD, MJ,Wayne Burton, MD,A. Mark Fendrick, MD,Donna M. Fick, RN, PhD,David Franklin, BA,Rebecca Killion, MA,Darius N. Lakdawalla, PhD,Peter J. Neumann, ScD,Kavita Patel, MD, MSHS,John Yee, MD, MPH,Brian Sakurada, PharmD,Kristina Yu-Isenberg, PhD, MPH, RPh New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
Evaluating HCV Screening, Linkage to Care, and Treatment Across Insurers
ByKaren Mulligan, PhD,Jeffrey Sullivan, MS,Lara Yoon, MPH,Jacki Chou, MPP, MPL,Karen Van Nuys, PhD An optimized hepatitis C virus screening and linkage-to-care process reduces the number of patients lost to follow-up and improves linkage to care for Medicare, Medicaid, and commercially insured patients.
Modeling the Impacts of Restrictive Formularies on Patients With HIV
ByJames Baumgardner, PhD,Caroline Huber, MPH,Mina Kabiri, PhD,Lara Yoon, MPH,Jacki Chou, MPP, MPL,John Romley, PhD Constraining access to HIV regimens can have significant implications for patients. This study examined the economic and health impacts of restrictive HIV formulary designs.